Synergy CHC Corp. Revenue from Contract with Customer, Excluding Assessed Tax
Synergy CHC Corp. (SNYR) reported Revenue from Contract with Customer, Excluding Assessed Tax of $6.12 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-06-29.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2020-06-29
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-03-31 was $6.12M, a 35.40% decline year-over-year.
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-12-31 was $6.19M, a 18.88% increase year-over-year.
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-09-30 was $7.36M, a 19.87% decline year-over-year.
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-06-30 was $6.34M, a 34.87% decline year-over-year.
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for fiscal 2019 was $29.36M, a 13.21% decline from fiscal 2018.
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for fiscal 2018 was $33.82M, a 4.98% decline from fiscal 2017.
- Synergy CHC Corp. revenue from contract with customer, excluding assessed tax for fiscal 2017 was $35.60M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2020-03-31 | $6.12M 10-Q · filed 2020-06-29 | $12.30M derived: sum of 2 quarters · filed 2020-06-29 | $19.67M derived: sum of 3 quarters · filed 2020-06-29 | $26.01M derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-12-31 | $6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $13.55M derived: sum of 2 quarters · filed 2020-04-29 | $19.89M derived: sum of 3 quarters · filed 2020-04-29 | $29.36M 10-K · filed 2020-04-29 |
| 2019-09-30 | $7.36M 10-Q · filed 2019-11-14 | $13.70M derived: sum of 2 quarters · filed 2019-11-14 | $23.17M 10-Q · filed 2019-11-14 | $28.37M derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-06-30 | $6.34M 10-Q · filed 2019-08-13 | $15.81M 10-Q · filed 2019-08-13 | $21.01M derived: sum of 3 quarters · filed 2020-06-29 | $30.20M derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-03-31 | $9.47M 10-Q · filed 2020-06-29 | $14.67M derived: sum of 2 quarters · filed 2020-06-29 | $23.86M derived: sum of 3 quarters · filed 2020-06-29 | $33.59M derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $14.39M derived: sum of 2 quarters · filed 2020-04-29 | $24.12M derived: sum of 3 quarters · filed 2020-04-29 | $33.82M 10-K · filed 2020-04-29 |
| 2018-09-30 | $9.19M 10-Q · filed 2019-11-14 | $18.92M derived: sum of 2 quarters · filed 2019-11-14 | $28.62M 10-Q · filed 2019-11-14 | $34.93M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $9.73M 10-Q · filed 2019-08-13 | $19.43M 10-Q · filed 2019-08-13 | $25.74M derived: sum of 3 quarters · filed 2019-08-13 | $34.92M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $9.70M 10-Q · filed 2019-05-03 | $16.01M derived: sum of 2 quarters · filed 2019-05-03 | $25.19M derived: sum of 3 quarters · filed 2019-05-03 | $34.51M derived: sum of 4 quarters · filed 2019-05-03 |
| 2017-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $15.49M derived: sum of 2 quarters · filed 2019-03-29 | $24.81M derived: sum of 3 quarters · filed 2019-03-29 | $35.60M 10-K · filed 2019-03-29 |
| 2017-09-30 | $9.18M 10-Q · filed 2018-11-13 | $18.49M derived: sum of 2 quarters · filed 2018-11-13 | $29.28M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $9.32M 10-Q · filed 2018-08-14 | $20.11M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |